Detalhe da pesquisa
1.
Clinical, genomic, and imaging predictors of myeloma progression from asymptomatic monoclonal gammopathies (SWOG S0120).
Blood
; 123(1): 78-85, 2014 Jan 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-24144643
2.
Jumping translocations of 1q12 in multiple myeloma: a novel mechanism for deletion of 17p in cytogenetically defined high-risk disease.
Blood
; 123(16): 2504-12, 2014 Apr 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-24497533
3.
Prognostic implications of serial 18-fluoro-deoxyglucose emission tomography in multiple myeloma treated with total therapy 3.
Blood
; 121(10): 1819-23, 2013 Mar 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-23305732
4.
Risk factors for MDS and acute leukemia following total therapy 2 and 3 for multiple myeloma.
Blood
; 121(23): 4753-7, 2013 Jun 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-23603914
5.
Second malignancies in total therapy 2 and 3 for newly diagnosed multiple myeloma: influence of thalidomide and lenalidomide during maintenance.
Blood
; 120(8): 1597-600, 2012 Aug 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-22674807
6.
Hepatitis B reactivation in patients with multiple myeloma and isolated positive hepatitis B core antibody: a call for greater cognizance.
Ann Hepatol
; 13(4): 461-5, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24927619
7.
Pharmacogenomics of bortezomib test-dosing identifies hyperexpression of proteasome genes, especially PSMD4, as novel high-risk feature in myeloma treated with Total Therapy 3.
Blood
; 118(13): 3512-24, 2011 Sep 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-21628408
8.
Standard and novel imaging methods for multiple myeloma: correlates with prognostic laboratory variables including gene expression profiling data.
Haematologica
; 98(1): 71-8, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-22733020
9.
Metronomic therapy is an effective salvage treatment for heavily pre-treated relapsed/refractory multiple myeloma.
Haematologica
; 98(7): 1147-53, 2013 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-23716540
10.
High-risk myeloma is associated with global elevation of miRNAs and overexpression of EIF2C2/AGO2.
Proc Natl Acad Sci U S A
; 107(17): 7904-9, 2010 Apr 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-20385818
11.
Superior results of Total Therapy 3 (2003-33) in gene expression profiling-defined low-risk multiple myeloma confirmed in subsequent trial 2006-66 with VRD maintenance.
Blood
; 115(21): 4168-73, 2010 May 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-20124509
12.
Total Therapy 3 for multiple myeloma: prognostic implications of cumulative dosing and premature discontinuation of VTD maintenance components, bortezomib, thalidomide, and dexamethasone, relevant to all phases of therapy.
Blood
; 116(8): 1220-7, 2010 Aug 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-20501894
13.
Extramedullary disease portends poor prognosis in multiple myeloma and is over-represented in high-risk disease even in the era of novel agents.
Haematologica
; 97(11): 1761-7, 2012 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-22689675
14.
Gene expression profiling of plasma cells at myeloma relapse from tandem transplantation trial Total Therapy 2 predicts subsequent survival.
Blood
; 113(26): 6572-5, 2009 Jun 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-19389881
15.
Complete remission in multiple myeloma examined as time-dependent variable in terms of both onset and duration in Total Therapy protocols.
Blood
; 114(7): 1299-305, 2009 Aug 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-19515721
16.
Thalidomide arm of Total Therapy 2 improves complete remission duration and survival in myeloma patients with metaphase cytogenetic abnormalities.
Blood
; 112(8): 3115-21, 2008 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-18492953
17.
TP53 deletion is not an adverse feature in multiple myeloma treated with total therapy 3.
Br J Haematol
; 147(3): 347-51, 2009 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-19702643
18.
Waldeström macroglobulinaemia relapsing with focal bone disease and achieving major response with single-agent zoledronic acid.
Br J Haematol
; 163(3): 293, 2013 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-23930696
19.
Correction: Spectrum of Cerebrovascular Disease in Patients with Multiple Myeloma Undergoing Chemotherapy-Results of a Case Control Study.
PLoS One
; 12(3): e0175218, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28358855
20.
Assessment of Total Lesion Glycolysis by 18F FDG PET/CT Significantly Improves Prognostic Value of GEP and ISS in Myeloma.
Clin Cancer Res
; 23(8): 1981-1987, 2017 04 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27698001